LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

Sustained efficacy up to 4.5 years of a bivalent
L1 virus-like particle vaccine
against human papillomavirus types 16
and 18: follow-up from a randomised
control trial. Lancet 2006 Apr 15; 367
(9518):1247-55.
96. Harrison A, Karim SA, Floyd K, Lombard
C, Lurie M, Ntuli N, Wilkinson D. Syndrome
packets and health worker training
improve sexually transmitted disease
case management in rural South Africa:
randomized controlled trial. AIDS 2000
Dec 1; 14(17):2769-79.
97. Hawkes S, Mabey D, Mayaud P. Partner
notification for the control of sexually
transmitted infections. BMJ 2003 Sep 20;
327(7416):633-4.
98. Hawkes S, Miller S, Reichenbach L, Nayyar
A, Buses K. Antenatal syphilis control:
people, programmes, policies and politics.
Bull World Health Organ 2004 Jun;
82 (6):417-23.
99. Health Protection Agency. Guidelines for
managing outbreaks of Sexually Transmitted
Infections 2003. Acceso el 13/3/
2006 en: http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/guidelines/managing_outbreaks_of_sti.htm.
100. Health Protection Agency. Mapping the
Issues - HIV and other Sexually Transmitted
Infections in the United Kingdom:
2005. En: http://www.hpa.org.uk/hpa/
publications/hiv_sti_2005; acceso el
13/3/2006.
101. Henry K. Documented male-to-female
transmission of HIV-1 after minimal vaginal
exposure in the absence of other cofactors
for infection. Minn Med 1991 Oct;
74(10):32-4.
102. Herida M, Michel A, Goulet V, Janier M,
Sednaoui P, Dupin N, de Barbeyrac B, Semaille
C. [Epidemiology of sexually
transmitted infections in France]. Med
Mal Infect 2005 May; 35(5):281-9.
103. Herkert M, Melsheimer P, Reichert A,
Trunk M, Oed M, Wentzensen N, Ridder R
and von Knebel Doeberitz M. Detection
of p16INK4a in cell lysates of cervical
swabs by a simple ELISA assay allows to
identify patients with high grade cervical
dysplasia. 22nd International Papillomavirus
Conference and Clinical Workshop
2005. Oral Poster – 61.
104. Hira SK, Feldblum PJ, Kamanga J, Mukelabai
G, Weir SS, Thomas JC. Condom and
nonoxynol-9 use and the incidence of
HIV infection in serodiscordant couples
in Zambia. Int J STD AIDS 1997 Apr; 8(4):
243-50.
105. Hobfoll S, Jackson AP, Lavin J, Britton PJ,
Shepherd JB. Reducing inner-city women’s
AIDS risk activities: a study of single,
pregnant women. Health Psychology
1994; 13(5):397-403.
106. Hogewoning C, Bleeker M, Van den Brule
A, Voorhorst F, Snijders P, Berkhof J, et al.
Condom use promotes regression of cervical
intraepithelial neoplasia and clearance
of human papilloma virus: a randomized
clinical trial. Int J Cancer 2003; 107;
811-16.
107. Holmes J, Hemmett L, Garfield S. The
cost-effectiveness of human papillomavirus
screening for cervical cancer. A review
of recent modelling studies. Eur J
Health Econ 2005 Mar; 6(1):30-7.
108. Holmes KK, Levine R, Weaver M. Effectiveness
of condoms in preventing sexually
transmitted infections. Bull World
Health Organ 2004; 82(6): 454-461.
109. Holmes KK, Mard PA, Sparling PF, Lemon
SM, Stamm WE, Piot P, Wasserheit JN. Sexually
transmitted diseases 1999. McGraw-Hill.
New York.
110. Honey E, Augood C, Templeton A, Russell
I, Paavonen J, Mardh P A, Stary A,
Stray-Pedersen B. Cost effectiveness of
screening for Chlamydia trachomatis: a
review of published studies. Sexually
Transmitted Infections 2002; 78(6):
406-412.
163